PRPO logo

Precipio, Inc. Stock Price

NasdaqCM:PRPO Community·US$50.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

PRPO Share Price Performance

US$27.90
22.21 (390.33%)
US$27.90
22.21 (390.33%)
Price US$27.90

PRPO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks
1 Reward

Precipio, Inc. Key Details

US$24.0m

Revenue

US$13.3m

Cost of Revenue

US$10.7m

Gross Profit

US$11.1m

Other Expenses

-US$363.0k

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.20
44.52%
-1.51%
0.5%
View Full Analysis

About PRPO

Founded
n/a
Employees
66
CEO
Ilan Danieli
WebsiteView website
www.precipiodx.com

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Recent PRPO News & Updates

Recent updates

No updates